Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes

NCT06746610 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.

NCT NCT06746610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06746610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
Lead sponsor
Tianjin Medical University General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2022
Completion date
July 31, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monogenic diabetes